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Abstract
Background: The extent of post-mortem detection of specific psychoactive drugs may differ between countries,
and may greatly influence the national death register’s classification of manner and cause of death. The main
objective of the present study was to analyse the magnitude and pattern of post-mortem detection of various
psychoactive substances by the manner of death (suicide, accidental, undetermined and natural death with a
psychiatric diagnosis) in Norway and Sweden.
Methods: The Cause of Death Registers in Norway and Sweden provided data on 600 deaths in 2008 from each
country, of which 200 were registered as suicides, 200 as accidents or undetermined manner of death and 200 as
natural deaths in individuals with a diagnosis of mental disorder as the underlying cause of death. We examined
death certificates and forensic reports including toxicological analyses.
Results: The detection of psychoactive substances was commonly reported in suicides (66 and 74% in Norway and
Sweden respectively), accidents (85 and 66%), undetermined manner of deaths (80% in the Swedish dataset) and in
natural deaths with a psychiatric diagnosis (50 and 53%). Ethanol was the most commonly reported substance in
the three manners of death, except from opioids being more common in accidental deaths in the Norwegian
dataset. In cases of suicide by poisoning, benzodiazepines and z-drugs were the most common substances in both
countries. Heroin or morphine was the most commonly reported substance in cases of accidental death by
poisoning in the Norwegian dataset, while other opioids dominated the Swedish dataset. Anti-depressants were
found in 22% of the suicide cases in the Norwegian dataset and in 29% of suicide cases in the Swedish dataset.
Conclusions: Psychoactive substances were detected in 66 and 74% of suicides and in 85 and 66% of accidental
deaths in the Norwegian and Swedish datasets, respectively. Apart from a higher detection rate of heroin in deaths
by accident in Norway than in Sweden, the pattern of detected psychoactive substances was similar in the two
countries. Assessment of a suicidal motive may be hampered by the common use of psychoactive substances in
suicide victims.
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Background
Substance abuse is a major public health problem and a
risk factor for premature death in intentional, accidental,
and natural circumstances, and can have a severe
economic, emotional, and society impact on individuals,
families and within communities [1–3]. In forensic medi-
cine, determination of manner of death as intentional or
accidental can be particularly challenging in deaths caused
by poisoning or related to substance abuse, where there is
no clear evidence for suicidal intention.. Hence, the
frequency and accuracy of post-mortem examinations,
including toxicological analyses, may ultimately impact
death statistics [4]. In the USA, the percentage of drug
poisoning classified as having undetermined manners of
death range from 1 to 85% between states and specifica-
tion of the drugs involved varies by type of death investi-
gation system [5].
Few studies have systematically examined the post-
mortem occurrence of psychoactive substances accord-
ing to classified manner of death: natural death, acci-
dent, suicide or undetermined manner of death. In a
large observational study from England on drug-related
fatal injuries, the most frequent substance detected was
alcohol (36%), followed by sedative-hypnotics, cannabis,
heroin and cocaine. Antidepressants were more often
detected in intentional fatal injuries (suicides by other
methods than poisoning) compared with accidents (12%
vs 2%) [6]. An important proportion of suicides is
committed by mentally ill persons that are or have been
treated with psychoactive prescription drugs [7–9].
Hence, it is likely that such drugs are commonly
detected in this category of deaths. In a Swedish study
on suicides by hanging and poisoning, paracetamol, cita-
lopram, diazepam, sedative antihistamines, and zopi-
clone were amongst the top-ten drugs detected [10].
Opioid poisoning is relatively frequent among drug
abusers [11], and the associated manner of death may be
registered as a suicide, accident or natural death [12].
The pattern of substance abuse varies between countries.
Norway reports a relatively high prevalence of intraven-
ous drug abuse compared with the other Scandinavian
countries, Sweden and Denmark [13, 14]. In all three
countries, among drug abusers, poisoning by opioids is
reported as the main cause of death, with methadone
more commonly detected in deaths in Denmark and
Sweden, and heroin/morphine in Norway [14]. Regional
differences in substance abuse may reflect general avail-
ability, but aside from opioid overdoses, less is known
about patterns of toxicological findings in the general
population of suicides and accidents in Scandinavia.
Since a peak in 2001, there has been no definite decline
in deaths due to accidental poisoning in Norway [15].
According to the Swedish official death statistics there
has been a gradual increase of drug related deaths with
some fluctuations during the past five decades and a
marked increase during the period 2006–2014 [16]. In
the latter period, the rate of drug related deaths in-
creased from 3.6 to 8.1 per 100.000 inhabitants per year,
and most of the deaths involved opioid overdose [14].
In order to enable societies to implement relevant pre-
vention strategies to reduce premature deaths, increased
knowledge about related substance abuse patterns is
necessary. The main purpose of this study was to analyse
the occurrence and pattern of various psychoactive
substances in a population of suicides and accidents as
well as in natural deaths with a psychiatric diagnosis. In
addition to describe patterns of substance findings
according to manner of death, and deaths due to acute
poisoning versus other methods, we aimed to compare
datasets from two neighbouring countries; Norway and
Sweden.
Methods
Description of data
This study includes data of the deaths of 1200 persons aged
18 years and older, 600 from Norway and 600 from Sweden
from the year 2008. It follows a previous assessment of the
reliability of suicide statistics in Scandinavia [17].
From the Cause of Death Registers for each country,
we retrieved data on 200 deaths registered as suicides,
200 as accidents or undetermined manner of death and
200 as natural deaths (i.e. death as a result of a disease
or an internal malfunction of the body not caused by ex-
ternal forces or poisoning). The suicide sample included
suicide by all methods (ICD-10: X60–X84, Y870). The
accidents and undetermined manners of death covered
traffic accidents (ICD-10: V43–V45.5, V47–V48.5,
V49.4), accidental poisoning (ICD-10: X40–X49), acci-
dental drowning (ICD-10: W65–W74), accidental fire
and flame (ICD-10: X00–X09) and undetermined intent
(ICD-10: Y10–Y34, Y872). The Norwegian dataset in-
cluded no cases of undetermined intent, as no deaths
were registered under this category in the Norwegian
Cause of Death Register in 2008.
Since we hypothesised that psychoactive substances
would also be commonly detected among forensically
examined natural deaths with mental illness as the
underlying cause of death, this group were also included
for comparative purposes. These included ‘mental and
behavioural disorders due to psychoactive substance use’
(ICD-10: F10–F19), ‘schizophrenia, schizotypal and delu-
sional disorders’ (ICD-10: F20–F29), ‘mood (affective)
disorders’ (ICD-10: F30–F39) and ‘disorders of adult per-
sonality and behaviour’ (ICD-10: F60–F69).
Material
In Norway and Sweden, it is mandatory for physicians to
report all suspected unnatural deaths to the police, who
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then decide whether a forensic autopsy shall be per-
formed. In Norway, only some of the centres that per-
form forensic autopsies submit a complete autopsy
report to the Norwegian Cause of Death Register,
whereas the others submit a revised death certificate. In
the Norwegian sample of 600 deaths, forensic autopsies
had been performed in 325 (54%) of cases, and for 266
of these, a complete autopsy report was available. For
the remaining 59 cases, revised death certificates were
available. In the Swedish dataset, a forensic autopsy had
been performed in 483 (81%) of the 600 cases, a
complete autopsy report was available for 469 cases and
we used revised death certificates for the remaining 14
(Table 1). A more detailed description of the data mater-
ial and study population has been published previously
[17].
For the forensic autopsy cases, accounts of psycho-
active substance findings were based on information
given on the revised death certificates or in the autopsy
report. However, for the Norwegian cases in particular,
the content of the autopsy reports and revised death
certificates differed in their levels of detail regarding
results of the toxicological analyses. In deaths due to
causes other than poisoning, results of possible toxico-
logical analyses were not always stated. Further, in some
deaths due to poisoning (suicide or accident), only the
main agent was stated, while other toxicological results
were probably omitted. A complete statement on toxico-
logical findings outlining both positive and negative re-
sults was available for 233 of the Norwegian cases (39%)
and 449 (75%) of the Swedish cases.
Toxicological analyses
Detected psychoactive substances in blood, urine, other
body fluids, muscle or hair were classified as alcohols
(ethanol or toxic alcohols), opioids (heroin/morphine or
other opioids), cannabinoids, psychostimulants (amphet-
amine/methamphetamine, cocaine/benzoylecgonine,
ecstasy, 3-methoxy-4-methylamphetamine and related
substances), benzodiazepines and z-drugs (zolpidem and
zopiclone), sedative antihistamines (alimemazine,
promethazine, dexchlorpheniramine, hydroxyzine and
related substances), anti-depressants (selective serotonin
reuptake inhibitors [SSRIs], serotonin and noradrenaline
reuptake inhibitors, and other anti-depressants),
antipsychotics, antiepileptics and other or unspecified
psychoactive substances. Metabolites were classified
accordingly. In morphine positive cases, low concentra-
tions of codeine were assumed to be derived from intake
of heroin/morphine. The detection of ethanol confined
to urine was most likely a post-mortem occurrence and
was not included in the analyses.
Statistics
We used the Statistical Package for Social Science (ver-
sion 23.0; SPSS Inc., Armonk, NY, USA). We present
estimates of post-mortem forensic findings by the man-
ner of death (suicide, accidental, undetermined and
natural death) in the Norwegian and Swedish datasets as
numbers and percentages. Proportions of detected sub-
stances were compared between suicides and accidents
in each country using chi-squared tests. Chi-squared
tests were also used to compare the frequency of
psychoactive substances in suicides/accidents by poison-
ing between the Norwegian and Swedish datasets.
Two-sided P-values < 0.05 were regarded as statistically
significant.
Results
Psychoactive substances in suicides, accidents and natural
deaths
Post-mortem detection of psychoactive substances was
commonly reported for suicides (66 and 74%), acci-
dents (85 and 66%), undetermined manner of death
(80%, Swedish dataset only) as well as in natural
deaths with a psychiatric diagnosis (50 and 53%) in
the Norwegian and Swedish datasets, respectively
(Table 2). In both countries and in all manners of
death, detection of ethanol was most frequent (27–
38%), with the exception of accidents in the Norwe-
gian dataset, where opioids were the most frequent
(55%). In both the Norwegian and Swedish datasets,
opioids, cannabinoids and psychostimulants were
more frequently reported in accidents than in suicides
(P < 0.05). Anti-depressants were detected in 22 and
29% of the suicides in the Norwegian and Swedish
datasets, respectively. Among undetermined deaths in
the Swedish dataset, anti-depressants (37%) and ben-
zodiazepines (37%) were the most frequently reported
substances, and opioids (34%) and ethanol (34%) the
second. In natural deaths with a psychiatric diagnosis,
the detection of psychoactive substances other than
ethanol was relatively rare in both countries.
Table 1 Sample characteristics
Total Norway Sweden
Total number of cases (n) 1200 600 600
Natural deaths 200 200
Suicides 200 200
Accidents 200 140
Undetermined manner of death 0 60
Performed autopsy (n) 808 (67%) 325 (54%) 483 (81%)
Natural deaths 32 (16%) 108 (54%)
Suicides 136 (68%) 192 (96%)
Accidents 157 (79%) 124 (89%)
Undetermined manner of death 59 (98%)
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Suicides and accidents by poisoning
Among suicides by poisoning, benzodiazepines and
z-drugs were the most commonly detected psychoactive
substances in the Norwegian (62%) and Swedish (46%)
datasets (Tables 3 and 4). Ethanol, anti-depressants and
opioids were also common in this category of deaths.
Detection of antipsychotic drugs and sedative antihista-
mines differed in the two datasets. Antipsychotic drugs
were detected in 24% of suicides by poisoning in the
Norwegian dataset but in only 7% of the Swedish dataset
(P < 0.05). Among suicides by poisoning in the Swedish
dataset, sedative antihistamines were the second most
common substance group (41%) but were detected in
only 11% of the Norwegian cases (P < 0.01). Detection of
psychostimulants such as amphetamine/methampheta-
mine and cocaine were more common among poisoning
suicides in Norway (14%) compared with Sweden (2%).
In both datasets, among accidents by poisoning,
opioids were the most commonly detected psychoactive
substance (Table 3), with a significantly higher prevalence
in the Norwegian dataset (73%) than in the Swedish data-
set (57%; P < 0.05). Of the opioids, heroin/morphine was
more frequent in the Norwegian dataset (56% vs. 21%; P <
0.001), while other opioids were more frequent in the
Swedish dataset (23% vs. 42%; P < 0.05). In both countries,
benzodiazepines, z-drugs, ethanol, psychostimulants and
anti-depressants were also commonly detected in acci-
dents by poisoning. Ethanol (29% vs. 44%; P < 0.05) and
sedative antihistamines (7% vs. 19%; P < 0.05) were more
frequently detected in the Swedish dataset of accidents by
poisoning.
Suicides and accidents by methods other than poisoning
The detection of psychoactive substances was also
common in suicides and accidents not caused by poison-
ing (Tables 3 and 4). Among suicides by methods other
than poisoning, psychoactive substances were detected
in 59% of the Norwegian dataset and 64% of the Swedish
Table 2 Detection of psychoactive substances in all deaths, n (%)
Norway Sweden
Natural
deaths n = 32
Suicides
n = 136
Accidents
n = 157
P-value
(×2)
Natural deaths
n = 108
Suicides
n = 192
Accidents
n = 124
Undetermined
deaths n = 59
P-value
(× 2)
Alcohols 10 (31) 36 (27) 49 (31)o 0.650 37 (34) 73 (38) 44 (36) o 20 (34) 0.894
Ethanol 10 (31) 36 (27) 47 (30) 37 (34) 73 (38) 44 (36) 20 (34)
Toxic alcoholsa 0 1 (1) 2 (1) 0 0 0 0
Opioids 1 (3) 16 (12) 87 (55)*** < 0.001 10 (9) 27 (14) 38 (31)*** 20 (34) < 0.001
Heroin/morphine 0 7 (5) 65 (41) 2 (2) 4 (2) 13 (11) 6 (10)
Other opioidsb 1 (3) 11 (8) 30 (19) 9 (8) 25 (13) 29 (23) 18 (31)
Cannabinoids 2 (6) 6 (4) 20 (13)* 0.036 4 (4) 3 (2) 10 (8)** 3 (5) 0.042
Psychostimulantsc 1 (3) 10 (7) 24 (15)* 0.031 3 (3) 6 (3) 15 (12)** 4 (7) 0.004
Benzodiazepines and z-
drugsd
3 (9) 46 (34) 64 (41)o 0.003 12 (11) 49 (26) 30 (24)o 22 (37) 0.001
Sedative antihistaminese 1 (3) 9 (7) 8 (5)o 0.698 8 (7) 33 (17) 14 (11)o 14 (24) 0.013
Antidepressants 3 (9) 30 (22) 23 (15)o 0.114 7 (7) 56 (29) 21 (17)* 22 (37) < 0.001
SSRI/SNRI 3 (9) 21 (15) 15 (10) 6 (6) 50 (26) 17 (14) 19 (32)
Other antidepressants 0 12 (9) 12 (8) 1 (1) 16 (8) 8 (7) 5 (9)
Antipsychotics 2 (6) 16 (12) 12 (8)o 0.396 1 (1) 6 (3) 5 (4)o 2 (3) 0.543
Antiepilepticsf 0 7 (5) 10 (6)o 0.336 7 (7) 11 (6) 4 (3)o 2 (3) 0.600
Other/unspecified
psychoactive agentsg
3 (9) 12 (9) 19 (12)o 0.644 1 (1) 5 (3) 1 (1)o 3 (5) 0.205
Any psychoactive agent 16 (50) 90 (66) 134 (85)*** < 0.001 57 (53) 142 (74) 82 (66)o 47 (80) < 0.001
aMethanol, isopropanolol
bMethadone, buphrenorphine, oxycodone, ketobimedone, tramadol, fentanyl, dextropropoxyphene. Includes combination drugs containing codeine, but not
codeine assumed to be derived from heroin/morphine
cAmphetamine/methamphetamine, cocaine/benzoylecgonine, MMA, ecstasy and related substances
dZolpidem and zopiclone
eAlimemazine, promethazine, dexchlorfeniramine, hydroxyzine and related substances
fKarbamazepin, lamotrigin, fenobarbital, gabapentin, pregabalin, fenytoin, topiramat (not benzodiazepines)
gGHB, nimbex, tiopental, baclofen, propofol, ketamin, butan, orfenadrin, somadril/karsiprodol, biperiden, kloroxazon
oAccidents not significantly different from suicides (p-value > 0.05)
*Accidents significantly different from suicides (p-value < 0.05)
**Accidents significantly different from suicides (p-value < 0.01)
***Accidents significantly different from suicides (p-value < 0.001)
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dataset. Among accidents other than by poisoning, psy-
choactive substances were reported in 58% of the
Norwegian dataset and in 37% of the Swedish dataset.
Ethanol was reported in 22% of Norwegian and 38% of
Swedish datasets for ‘non-poisoning’ suicides, and in 33
and 27% of ‘non-poisoning’ accidents, respectively.
Discussion
This study confirms a high frequency of psychoactive
substance detection in post-mortem examinations of
deaths classified as suicides or accidents as reported by
previous studies [18–23]. Substances other than ethanol
were less commonly detected in natural deaths with a
psychiatric diagnosis.
In accidental deaths by poisoning, opioids were the
most commonly reported substances in both the Norwe-
gian and Swedish datasets. However, while heroin and
morphine dominated in the Norwegian dataset, other
opioids dominated in the Swedish dataset. These find-
ings are in accordance with those of previous studies
[14, 24] and probably reflect national differences in the
availability of illicit and prescription opioids in the two
countries. In the recent years, the general tendency in
the Scandinavian countries has been that medicinal opi-
oids are replacing heroin, possibly connected to a gen-
eral decline in heroin availability around 2010/2011 [25].
Furthermore, strong opioids (morphine, fentanyl and
oxycodone) are also becoming more frequently pre-
scribed for pain in Sweden [26] and the use of opioids in
opioid agonist therapy for problematic drug users is
increasing as an effect of the less rigorous regulations
introduced in 2005 [27]. According to a recent Swedish
study, 24% of 400 patients in opioid agonist therapy
reported that they had diverted methadone or buprenor-
phine to other people “in the last month” [28]. Similarly,
a Finnish study found that 20% of patients gave away or
sold their doses [29].
Even though the suicide statistics in Scandinavia has
been found to be quite reliable [17], the state of mind of
the suicide victims may be difficult to assess when so
many were under the influence of psychoactive
substances at the time of death.
In suicide victims, the prevalence of ethanol was simi-
lar to that found in previous studies in Norway and
Table 3 Psychoactive substances in deaths by poisoning and all other causes, according to manner of death, n (%)
Norway Sweden
Suicides Accidents Suicides Accidents Undetermined deaths
Poisoning
n = 37
Other
n = 99
Poisoning
n = 112
Other
n = 45
Poisoning
n = 56
Other
n = 136
Poisoning
n = 62
Other
n = 62
Poisoning
n = 33
Other
n = 26
Ethanol 14 (38) 22 (22) 32 (29)o 15 (33) 22 (39) 51 (38) 27 (44)o 17 (27) 11 (33)o 9 (35)
Opioids 12 (32) 4 (4) 82 (73)*** 5 (11) 19 (34) 8 (6) 35 (57)* 3 (5) 19 (58)* 1 (4)
Heroin/morphine 4 (11) 3 (3) 63 (56) 2 (4) 3 (5) 1 (1) 13 (21) 0 6 (18) 0
Other opioidsa 9 (24) 2 (2) 26 (23) 4 (9) 18 (32) 7 (5) 26 (42) 3 (5) 17 (52) 1 (4)
Psychostimulantsb 5 (14) 5 (5) 23 (21)o 1 (2) 1 (2) 5 (4) 14 (23)** 1 (2) 3 (9)o 1 (4)
Cannabinoids 0 6 (6) 16 (14)* 4 (9) 2 (4) 1 (1) 10 (16)* 0 3 (9)o 0
Benzodiazepines and z-drugsc 23 (62) 23 (23) 57 (51)o 7 (16) 26 (46) 23 (17) 27 (44)o 3 (5) 19 (58)o 3 (12)
Sedative antihistaminesd 4 (11) 5 (5) 8 (7)o 0 23 (41) 10 (7) 12 (19)* 2 (3) 13 (39)o 1 (4)
Antidepressants 13 (35) 17 (17) 20 (18)* 3 (7) 23 (41) 33 (24) 17 (27)o 4 (7) 18 (55)o 4 (15)
SSRI/SNRI 8 (22) 13 (13) 13 (12) 2 (4 18 (32) 32 (24) 14 (23) 3 (5) 15 (46) 4 (15)
Other antidepressants 7 (19) 5 (5) 10 (9) 2 (4) 12 (21) 4 (3) 6 (10) 2 (3) 5 (15) 0
Antipsychotics 9 (24) 7 (7) 11 (10)* 1 (2) 4 (7) 2 (2) 5 (8)o 0 2 (6)o 0
Antiepilepticse 6 (16) 1 (1) 9 (8) o 1 (2) 7 (13) 4 (3) 3 (5)o 1 (2) 2 (6)o 0
Other/unspecified psychoactive agentf 4 (11) 8 (8) 18 (16)o 1 (2) 3 (5) 2 (2) 1 (2)o 0 3 (9)o 0
Any psychoactive agent 32 (87) 58 (59) 108 (96)* 26 (58) 55 (98) 87 (64) 59 (95)o 23 (37) 33 (100)o 14 (54)
aMethadone, buphrenorphine, oxycodone, ketobimedone, tramadol, fentanyl, dextropropoxyphene. Includes combination drugs containing codeine, but not
codeine assumed to be derived from heroin/morphine
bAmphetamine/methamphetamine, cocaine/benzoylecgonine, MMA, ecstasy and related substances
cZolpidem and zopiclone
dAlimemazine, promethazine, dexchlorfeniramine, hydroxyzine and related substances
eKarbamazepin, lamotrigin, fenobarbital, gabapentin, pregabalin, fenytoin, topiramat (not benzodiazepinesf GHB, nimbex, tiopental, baclofen, propofol, ketamin,
butan, orfenadrin, somadril/karsiprodol, biperiden, kloroxazon
fGHB, nimbex, tiopental, baclofen, propofol, ketamin, butan, orfenadrin, somadril/karsiprodol, biperiden, kloroxazon
oAccidents/undetermined deaths by poisoning not significantly different from suicides by poisoning (p-value > 0.05)
*Accidents/undetermined deaths by poisoning not significantly different from suicides by poisoning (p-value < 0.05)
**Accidents/undetermined deaths by poisoning not significantly different from suicides by poisoning (p-value < 0.01)
***Accidents/undetermined deaths by poisoning not significantly different from suicides by poisoning (p-value < 0.001)
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Sweden [11–13], and was relatively high (22–39%)
regardless of suicide method. In a Polish survey, suicide
under the influence of alcohol was strongly associated
with alcohol dependence [30], emphasizing the import-
ance of suicidal risk assessment in healthcare for this
patient group.
More than half of all people who die by suicide meet
criteria for current depressive disorder [31]. There is
strong evidence that anti-depressant use and psychother-
apy may prevent or reduce affective mental disorders
[32]. Anti-depressants were detected in only 22% of
Norwegian and 29% of Swedish cases classified as
suicides in the present datasets, and antipsychotics were
detected in only 12 and 3% of the cases, respectively.
This might indicate either low detection or diagnosis of
mental diseases, an insufficient prescription of relevant
drugs, or low compliance with regard to the medical
treatment of psychiatric disorders in the population at
risk. In other terms, low detection of anti-depressants
among suicide victims may reflect a potential to reduce
suicide rates through improvements in treatment. How-
ever, there is conflicting evidence about a potential
correlation between the use of anti-depressants and
suicide rates. Sales figures of SSRIs in Norway and
Sweden had a fivefold increase in 1990–2006, but no
inverse relationship between the increase in sales of
SSRIs and declining suicide rates has been found [33]. A
Finnish study of suicide among those with major depres-
sion reported that only 3% had received anti-depressants
in an adequate (therapeutic) dosage, and none of those
with severe psychoses had received adequate psycho-
pharmacological treatment [34].
In the Swedish dataset, sedative antihistamines were
the second most commonly detected substance in
suicides by poisoning and were also commonly detected
in accidental poisoning cases, whereas in the Norwegian
dataset the prevalence of benzodiazepines and z-drugs
was higher. This indicates that for sleep disorders,
antihistamines are more commonly prescribed than ben-
zodiazepines and z-drugs in Sweden compared with
Norway.
Anti-depressants, benzodiazepines, opioids and etha-
nol were detected in about one-third of the Swedish
cases classified as undetermined manner of death. The
Table 4 Psychoactive substances according to suicide method, n (%)
Intentional self-poisoning ICD-
10: X60-X69
Intentional self-harm by hanging,
strangulation and suffocation. ICD-10:
X70
Other intentional self-harm ICD-10:
X71-X75, X78, X80-X84, X870
Norway n = 37 Sweden n = 56 Norway n = 44 Sweden n = 67 Norway n = 55 Sweden n = 69
Ethanol 14 (38) 22 (39) o 10 (23) 26 (39) 12 (22) 25 (36)
Opioids 12 (32) 19 (34) o 3 (7) 2 (3) 1 (2) 6 (9)
Heroin/morphine 4 (11) 3 (5) 2 (5) 0 1 (2) 1 (1)
Other opioidsa 9 (24) 18 (32) 2 (5) 2 (3) 0 5 (7)
Cannabinoids 0 2 (4)o 4 (9) 1 (2) 2 (4) 0
Psychostimulantsb 5 (14) 1 (2)* 5 (11) 3 (5) 0 2 (3)
Benzodiazepines, z-drugsc 23 (62) 26 (46)o 12 (27) 13 (19) 11 (20) 10 (15)
Sedative antihistaminesd 4 (11) 23 (41)** 3 (7) 4 (6) 2 (4) 6 (9)
Antidepressants 13 (35) 23 (41)o 8 (18) 16 (24) 9 (16) 17 (25)
SSRI/SNRI 8 (22) 18 (32) 6 (14) 16 (24) 7 (13) 16 (23)
Other antidepressants 7 (19) 12 (21) 2 (5) 1 (2) 3 (6) 4 (6)
Antipsychotics 9 (24) 4 (7)* 3 (7) 1 (2) 4 (7) 1 (1)
Antiepilepticse 6 (16) 7 (13)o 1 (2) 3 (5) 0 1 (1)
Other/unspecified psychoactive agentf 4 (11) 3 (5)o 2 (5) 1 (2) 6 (11) 1 (1)
Any psychoactive agent 32 (87) 55 (98)* 26 (59) 41 (61) 32 (58) 46 (67)
aMethadone, buphrenorphine, oxycodone, ketobimedone, tramadol, fentanyl, dextropropoxyphene. Includes combination drugs containing codeine, but not
codeine assumed to be derived from heroin/morphine
bAmphetamine/methamphetamine, cocaine/benzoylecgonine, MMA, ecstasy and related substances
cZolpidem and zopiclone
dAlimemazine, promethazine, dexchlorfeniramine, hydroxyzine and related substances
eKarbamazepin, lamotrigin, fenobarbital, gabapentin, pregabalin, fenytoin, topiramat (not benzodiazepinesf GHB, nimbex, tiopental, baclofen, propofol, ketamin,
butan, orfenadrin, somadril/karsiprodol, biperiden, kloroxazon
fGHB, nimbex, tiopental, baclofen, propofol, ketamin, butan, orfenadrin, somadril/karsiprodol, biperiden, kloroxazon
oNo significant differences in suicides by poisoning in Norway and Sweden (p-value > 0.05)
*Significant differences in suicides by poisoning in Norway and Sweden (p-value < 0.05)
**Significant differences in suicides by poisoning in Norway and Sweden (p-value < 0.01)
***Significant differences in suicides by poisoning in Norway and Sweden (p-value < 0.00)
Gravensteen et al. BMC Psychiatry           (2019) 19:33 Page 6 of 9
pattern of psychoactive substances in this classification
differed from that found in suicides, accidental deaths
and natural deaths, implying the complexity of this
group.
While the prevalence of opioids among undetermined
deaths was similar to accidents, detection of prescription
drugs such as sedative antihistamines and anti-depressants
was higher and comparable to suicides. In a previous study,
conducted by our group, 21% of the undetermined deaths
in the Swedish data set were reclassified as suicides, while
the great majority was reclassified as accidents [17].
Strengths and limitations
Recent toxicological studies in suicides are limited to
single cities or a small geographical or societal region
[35–37]. To our knowledge, this is the first study that
has included nationwide data from two Scandinavian
countries, which allowed transnational comparison of
patterns of toxicological findings in suicides, accidental
deaths, natural deaths with a psychiatric diagnosis and
cases with an undetermined intent.
The present study is based on datasets comprising a
large proportion of cases within the extracted categories,
including adults of both genders in a nationwide sample
comparable to the official mortality statistics. The aut-
opsy rates in the two datasets corresponded with na-
tional death statistics [38, 39] and we consider the
internal validity of the study to be reasonable.
The study had some limitations. We might have missed
results of toxicological analyses that were not included in
the available autopsy reports or revised death certificates.
Furthermore, the relatively low autopsy rate in Norway
may limit the reliability of the rate of detected psycho-
active drugs and be responsible for the under-reporting of
substances not directly related to the cause of death. It
may even impact the validity of manner of death classifica-
tion, possibly resulting in a lower official suicide rate [40].
Implications and further research
Standards for post-mortem examinations and in particular
for toxicological analyses can give important information
in order to establish the cause of death. Mortality data is
an essential tool in transnational analyses that might iden-
tify preventable risk factors for premature deaths and
guide public health efforts to prevent those deaths. The
differences between Norway and Sweden in the frequency
of forensic autopsies and reporting of toxicological find-
ings, may affect cause as well as manner of death classifi-
cation. In Norway, only a small proportion (16%) of
deaths classified as natural deaths with a psychiatric diag-
nosis underwent autopsy, and there may be a risk of mis-
classified deaths by poisoning in this group.
A higher rate of forensic autopsies, including standard-
ized toxicological analyses, would result in more reliable
data on the presence of toxic agents, in cases of sudden
death with sparse clinical information in particular, and
in Norway in general. Better information on the related
circumstances, including the clinical history of the
deceased, is needed for a more reliable assessment of the
manner of death. In addition, information about the his-
tory of substance abuse and ingestion of toxic agents
before death may give a broader basis for the detection
of psychoactive substances.
The relatively low detection rate of anti-depressants in
deaths by suicide could indicate low compliance and/or
low treatment frequency of affective mental disorders in
Sweden and Norway, but this should be further assessed
in future research.
Conclusions
In a population sample based on forensic autopsies from
Norway and Sweden, post-mortem detection of psycho-
active substances was reported in more than two-thirds
of suicides and accidents, and in about half of natural
deaths in patients with a psychiatric diagnosis.
National differences in the pattern of detected psycho-
active substances existed. Ethanol was detected in about
one third of all deaths in each manner category, and was
the most commonly detected drug, except in accidental
deaths in the Norwegian dataset, where opioids were
most common. In both countries, detection of benzodi-
azepines and z-drugs was common in suicides by
poisoning. In the Swedish dataset, sedative antihista-
mines were almost as frequently detected as other tran-
quillizers. Among accidental deaths by poisoning in the
Norwegian dataset, heroin or morphine was the most
commonly detected drug, while other opioids dominated
in the Swedish dataset.
Anti-depressants were detected in 22% of the suicides in
the Norwegian dataset and in 29% in the Swedish dataset.
Other studies estimate that about 40–60% of suicide vic-
tims suffered from depression, and thus would be candi-
dates for the prescription of anti-depressants; thus, the
reason for the relatively low detection of anti-depressants
among the suicide cases in our study is unclear.
Abbreviations
SSRI: Selective serotonin reuptake inhibitors
Acknowledgements
We would like to give special thanks to our colleagues at the Department of
Acute Medicine for their feedback on this paper.
Funding
No funding.
Availability of data and materials
The data that support the findings of this study are available from the
Norwegian Institute of Public Health in Norway and the National Board of
Forensic Medicine in Sweden, but restrictions apply to the availability of these
data, which were used under license from the current study, and so are not
publicly available. Data are however available from the authors upon
Gravensteen et al. BMC Psychiatry           (2019) 19:33 Page 7 of 9
reasonable request and with permission of the Norwegian Institute of Public
Health in Norway and the National Board of Forensic Medicine in Sweden.
Authors’ contributions
IKG plotted all cases, performed the statistical analyses and wrote the
manuscript. IMT applied for all permissions in Norway, contributed to
conception and design, interpretation of data and revised the manuscript
critically. IT applied for permissions in Sweden, contributed to conception
and design, interpretation of data and revised the manuscript critically. SR
were consulted for stating main toxicological agent in some cases where
this was unclear in the forensic report, contributed to conception and
design, interpretation of data and revised the manuscript critically. OE, KHL
and EH participated in planning the study, interpretation of data and revised
the manuscript critically. All authors read and approved the final manuscript.
Ethics approval and consent to participate
This study was approved by the Regional Committee for Medical Research
Ethics in South-Eastern Norway. In addition, the Higher Prosecuting Authority
in Norway, the Norwegian Institute of Public Health and Oslo University Hos-
pital Data Inspectorate approved the study. The National Board of Forensic
Medicine and the National Board of Health and Welfare in Sweden also ap-
proved the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Forensic Sciences, Oslo University Hospital, Box 4950
Nydalen, N-0424 Oslo, Norway. 2Department of Behavioural Sciences in
Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University
of Oslo, Box 1111 Blindern, N-0317 Oslo, Norway. 3Division of Mental Health
and Addiction, Oslo University Hospital Ullevaal, Box 4956 Nydalen, N-0424
Oslo, Norway. 4Department of Surgical Sciences, Uppsala University, Box 256,
751 05 Uppsala, Sweden. 5Department of Social Medicine, University of
Copenhagen, Copenhagen, Denmark. 6Institute of Clinical Medicine,
University of Oslo, Box 1072 Blindern, N- 0316 Oslo, Norway. 7Division of
Medicine, Department of Acute Medicine, Oslo University Hospital Ullevaal,
Box 4950 Nydalen, N-0424 Oslo, Norway.
Received: 9 July 2018 Accepted: 4 January 2019
References
1. Wilcox HC, Conner KR, Caine ED. Association of alcohol and drug use
disorders and completed suicide: an empirical review of cohort studies.
Drug Alcohol Depend. 2004;76(Suppl):S11–9.
2. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A
meta-analysis. Br J Psychiatry. 1997;170:205–28.
3. Gruszecki AC, McGwin G Jr, Robinson CA Jr, Davis GG. The relationship of
drug abuse to unexplained sudden death. Arch Pathol Lab Med. 2008;
132(12):1903–6. https://doi.org/10.1043/1543–2165-132.12.1903.
4. Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of
autopsy-detected diagnostic errors over time: a systematic review. JAMA.
2003;289(21):2849–56.
5. Warner M, Paulozzi LJ, Nolte KB, Davis GG, Nelson LS. State variation in
certifying manner of death and drugs involved in drug intoxication deaths.
Acad Foren Path. 2013;3:231–7.
6. Oyefeso A, et al. Fatal injuries while under the influence of psychoactive
drugs: a cross-sectional exploratory study in England. BMC Public Health.
2006;6:148.
7. Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsa ET,
Kuoppasalmi KI, et al. Mental disorders and comorbidity in suicide. Am J
Psychiatry. 1993;150(6):935–40.
8. Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy
studies of suicide: a systematic review. Psychol Med. 2003;33(3):395–405.
9. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275
suicides: a meta-analysis. BMC Psychiatry. 2004;4:37.
10. Jones AW, Holmgren A, Ahlner J. Toxicology findings in suicides:
concentrations of ethanol and other drugs in femoral blood in victims of
hanging and poisoning in relation to age and gender of the deceased. J
Forensic Legal Med. 2013;(7):842–7. https://doi.org/10.1016/j.jflm.2013.06.027.
11. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among
young injection drug users in San Francisco: a 10-year follow-up of the UFO
study. Am J Epidemiol. 2012;175(4):302–8.
12. Bjornaas MA, Jacobsen D, Haldorsen T, Ekeberg O. Mortality and causes of
death after hospital-treated self-poisoning in Oslo: a 20-year follow-up. Clin
Toxicol (Phila). 2009;47(2):116–23.
13. Fugelstad A, Annell A, Rajs J, Agren G. Mortality and causes and manner of
death among drug addicts in Stockholm during the period 1981–1992. Acta
Psychiatr Scand. 1997;96(3):169–75.
14. Simonsen KW, Edvardsen HM, Thelander G, Ojanpera I, Thordardottir S,
Andersen LV, et al. Fatal poisoning in drug addicts in the Nordic countries
in 2012. Forensic Sci Int. 2015;248:172–80.
15. Gjersing L. Narkotikautløste dødsfall i Norge i 2016. Oslo:
Folkehelseinstituttet; 2017.
16. Official Statistics of Sweden. Dödsorsaker 2014 (Cause of death 2014).
2015; http://www.socialstyrelsen.se/publikationer2015/2015-8-1. (Accessed
15 Nov 2018.)
17. Tollefsen IM, Helweg-Larsen K, Thiblin I, Hem E, Kastrup MC, Nyberg U, et al.
Are suicide deaths under-reported? Nationwide re-evaluations of 1800
deaths in Scandinavia. BMJ Open. 2015;5(11):e009120.
18. Dhossche DM, Rich CL, Isacsson G. Psychoactive substances in suicides.
Comparison of toxicologic findings in two samples. Am J Forensic Med
Pathol. 2001;22(3):239–43.
19. Nordrum I, Eide TJ, Jørgensen L. Alcohol in a series of medico-legally
autopsied deaths in northern Norway 1973–1992. Forensic Sci Int. 2000;
110(2):127–37.
20. Bogstrand ST, Normann PT, Rossow I, Larsen M, Mørland J, Ekeberg Ø.
Prevalence of alcohol and other substances of abuse among injured
patients in a Norwegian emergency department. Drug Alcohol Depend.
2011;117(2–3):132–8.
21. Holmgren A, Jones AW. Demographics of suicide victims in Sweden in
relation to their blood–alcohol concentration and the circumstances and
manner of death. Forensic Sci Int. 2010;198(1–3):17–22.
22. Del Rio MC, Gomez J, Sancho M, Alvarez FJ. Alcohol, illicit drugs and
medicinal drugs in fatally injured drivers in Spain between 1991 ad 2000.
Forensic Sci Int. 2002;127:63–70. https://doi.org/10.1016/S0379-
0738(02)00116-0.
23. Turnbridge RJ, Keigan M, James FJ. The incidence of drugs and alcohol in
road traffic fatalities. TRL Report 495. Crowthorne: TRL; 2002.
24. Delaveris GJ, Teige B, Rogde S. Non-natural manners of death among users
of illicit drugs: substance findings. Forensic Sci Int. 2014;238:16–21.
25. European Monitoring Centre for Drug Addiction, EMCDDA. European Drug
Report, Trends and Developments. Chapter 1. Luxembourg: Publications
Office of the European Union; 2014. ISBN: 978-92-9168-694-0. https://doi.
org/10.2810/32306. http://www.emcdda.europa.eu/publications/edr/trends-
developments/2014_en. Accessed 16 Jan 2019.
26. Rhodin A. Ökad opioidanvändning kan leda till toleransökning
(increased use of opioids may lead to increased tolerance).
Läkartidningen. 2014;111:1974–7.
27. Socialstyrelsen (National board of Health and Welfare). Läkemedelsassisterad
behandling vid opiatberoende (Drug assisted treatment in opiate
dependency). 2015; http://www.socialstyrelsen.se/publikationer2015/2015-3-
35. Accessed 15 Nov 2018.
28. Johnson B, Richert T. Diversion of methadone and buprenorphine by
patients in opioid substitution treatment in Sweden: prevalence estimates
and risk factors. Int J Drug Polic. 2015;26:183–90.
29. Launonen E, Alho H, Kotovirta E, Wallace I, Simojoki K. Diversion of
opioid maintenance treatment medications and predictors for diversion
among Finnish maintenance treatment patients. Int J Drug Policy. 2015;
26:875–82.
30. Fudalej S, et al. Clinical and genetic risk factors for suicide under the
influence of alcohol in a polish sample. Alcohol Alcohol. 2009;44:437–42.
31. Hawton K, van Heeringen K. Suicide. Lancet. 2009;373:1372–81.
Gravensteen et al. BMC Psychiatry           (2019) 19:33 Page 8 of 9
32. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton R,
et al. Antidepressant drug effects and depression severity: a patient-level
meta-analysis. JAMA. 2010;303(1):47–53.
33. Zahl PH, De Leo D, Ekeberg Ø, Hjelmeland H, Dieserud G. The relationship
between sales of SSRI, TCA and suicide in the Nordic countries. BMC
Psychiatry. 2010;10:62.
34. Isometsa ET, Henriksson MM, Aro HM, Heikkinen ME, Kuoppasalmi KI,
Lonnqvist JK. Suicide in major depression. Am J Psychiatry. 1994;
151(4):530–6.
35. Taktak S, Kumral B, Unsal A, Ozdes T, Buyuk Y, Celik S. Suicidal hanging
in Istanbul, Turkey: 1979–2012 autopsy results. J Forensic Legal Med.
2015;33:44–9.
36. Tulapunt N, Phanchan S, Peonim V. Hanging fatalities in Central Bangkok,
Thailand: a 13-year retrospective study. Clin Med Insights Pathol. 2017;10.
https://doi.org/10.1177/1179555717692545.
37. Zerbini T, de Carvalho Ponce J, Mayumi Sinagawa D, Barbosa Cintra
R, Romero Muñoz D, Leyton V. Blood alcohol levels in suicide by
hanging cases in the state of Sao Paulo, Brazil. J Forensic Legal Med.
2012;19(5):294–6.
38. The Norwegian Society of Pathology. Årsmelding 2008. https://
legeforeningen.no/Fagmed/Den-norske-patologforening/DNP-stoff/
arsmeldinger/arsmelding-2008/. Accessed 16 Jan 2019.
39. The National Board of Forensic Medicine. Årsredovisning 2017. https://www.
rmv.se/om-oss/forskning/aktuell-statistik/. Accessed 16 Jan 2019.
40. Reseland S, Le Noury J, Aldred G, Healy D. National suicide rates 1961-2003:
further analysis of nordic data for suicide, autopsies and ill-defined death
rates. Psychother Psychosom. 2008;77(2):78–82. https://doi.org/10.1159/
000112884.
Gravensteen et al. BMC Psychiatry           (2019) 19:33 Page 9 of 9
